Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BTIG Downgrades Integra Lifesciences to Neutral

BTIG analyst Ryan Zimmerman downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Neutral.
byvishwanath@benzinga.com
September 15, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

BTIG analyst Ryan Zimmerman downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0